The Killing Sense is set in Paris. At its centre is Galway-born, London-based single mother Kate Wilde, who has managed to ...

Both sides are accusing each other of violations as the deadline nears for Israeli troops to withdraw from Lebanon.

Kailera Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing a broad pipeline of ...

MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver ...

Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.

About four years after launch, Orna Therapeutics Inc. signed its second major deal, this time validating the lipid nanoparticle delivery technology it acquired through its Renagade Therapeutics Inc.

The three-year partnership is another example of Vertex’s interest in improving on Casgevy, its CRISPR medicine for sickle ...

Vertex Pharmaceuticals Inc. will work with a Watertown biotech on new gene-editing therapies for people with sickle cell ...

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and ...

Four judges with different backgrounds explain their methods for picking winning entries at the Pennsylvania Farm Show.

Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...